LOCALLY ADVANCED OR METASTATIC LUNG CANCER
Clinical trials for LOCALLY ADVANCED OR METASTATIC LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC LUNG CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo targets rare lung cancer in new trial
Disease control Not yet recruitingThis study tests a combination of anlotinib pills and standard chemotherapy for people with a rare, advanced lung cancer that lacks the SMARCA4 gene. About 28 adults will receive the treatment in 21-day cycles to see how long it keeps the cancer from growing and what side effects…
Matched conditions: LOCALLY ADVANCED OR METASTATIC LUNG CANCER
Phase: PHASE2 • Sponsor: Zhijie Wang • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New program aims to bridge the trust gap between oncologists and latino patients
Knowledge-focused Not yet recruitingThis study tests a program called HOLA that teaches oncologists special communication skills to build better relationships with their Latino patients who have advanced cancer. Researchers will compare how strong the bond is between doctors who take the training and those who don'…
Matched conditions: LOCALLY ADVANCED OR METASTATIC LUNG CANCER
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC